01 / STRATEGY
Antigen & RNA Design
Antigen and neoantigen strategy, construct review, RNA architecture and expression-oriented study design.
PRECISION RNA · TRANSLATIONAL SCIENCE
From RNA design to scientific decision.
Research-stage platform development for oncology vaccines, metabolic therapeutics and non-viral RNA delivery. We connect molecular design, analytical insight and biological function to help programs move forward with confidence.
Independent RNA research · Partner-enabled execution
RNA ARCHITECTURE
DELIVERY → EXPRESSION → INSIGHT
Research expertise spanning
↗ Oncology vaccines↗ Metabolic therapeutics↗ LNP / LPX delivery↗ Translational immunology
Our expertise
Expertise that connects
molecules to medicine.
Tailored scientific development services spanning RNA design, delivery, analytics, biological function and technology transfer. Each project is scoped to its stage and evidence needs.
Discuss this service ↗
02 / DELIVERY
Non-Viral Delivery
LNP and lipoplex (LPX) formulation strategy, physicochemical characterization and delivery-performance comparisons.
03 / ANALYTICS
RNA Analytics & Quality
RNA identity and integrity, capping-related attributes, impurities, particle measurements and stability strategy.
04 / BIOLOGY
Potency & Immunology
Cell-based expression, functional potency and translational immune-response assessment for research programs.
05 / TRANSFER
CMC & Technology Transfer
Quality target product profiles, critical quality attributes, analytical gap assessments and technical transfer packages.
06 / ADVISORY
Program Leadership
Research strategy, specialized CRO coordination, program review and scientific decision support.
Research programs
Focused on complex
therapeutic challenges.
An integrated scientific framework, tailored to the disease biology and development decisions that matter.
Advance cancer vaccine ideas with stronger evidence.
Research-stage support linking antigen and RNA construct strategy to delivery, expression, immune profiling and preclinical decisions.
- Antigen and neoantigen evaluation
- RNA construct and expression analysis
- Innate and adaptive immune-response studies
- Preclinical and CMC development readiness
Metabolic research distinguishes RNA-encoded medicines from investigational active-vaccination concepts. All programs are research-stage; no clinical efficacy is implied.
How we work
From hypothesis to
decision-ready evidence.
A clear, stage-appropriate process built around defined deliverables, reproducibility and the scientific question behind each project.
01 —
Define the question
Align research objectives, program stage, decision criteria and study boundaries.
02 —
Design the study
Map constructs, assays, controls, analytical attributes and partner requirements.
03 —
Generate the data
Coordinate research execution in-house or through qualified external laboratories.
04 —
Interpret the results
Connect molecular quality, delivery behavior and biological performance.
05 —
Plan the next step
Document recommendations, risks and readiness for further development or transfer.
About NEXUS
Deep science. Clear decisions. Collaborative execution.
NEXUS RNA BioSolutions is a research-stage initiative drawing on capabilities across mRNA vaccine platform development, translational immuno-oncology, molecular engineering, regulated analytical workflows and global technology transfer.
We aim to help early-stage teams ask sharper scientific questions, design more informative studies, and navigate critical research-to-development transitions—without requiring them to build every capability internally.
Start a scientific conversation ↗What guides us
Built for scientific clarity.
Fit-for-purpose science
Each study is designed around a clear development question, relevant measurements and decision criteria.
Partner-enabled execution
Specialized synthesis, formulation and other capabilities can be sourced through independently qualified providers.
Responsible development
Research-stage scopes, honest regulatory boundaries, documentation and intellectual-property review are central to the work.
Let's connect
Have a program worth exploring?
Whether you're evaluating an oncology RNA candidate, studying metabolic therapeutic concepts, or preparing for your next CMC milestone, we'd be glad to learn about your scientific challenge.
↗ Discovery and feasibility conversations
↗ Research-stage projects and collaborations
↗ Flexible scopes with qualified technical partners